• Jarc Logo
JointActionRareCancers
  • Who we are
      • Mission statement
      • Associated Partners
      • Collaborating Partners
  • How we work
      • About us

        EU Joint Action on Rare Cancers (JARC)

        The framework for EU stakeholders and policy makers to work together, set the agenda at national level and help provide diagnostics, healthcare and support to all our citizens who suffer from rare cancer.

        More
      • Work packages

        • General Info
        • 01 - Coordination
        • 02 - Dissemination
        • 03 - Evaluation
        • 04 - Epidemiology
        • 05 - Assuring Quality of Care
        • 06 - Clinical practice guidelines
        • 07 - Innovation and access to innovation
        • 08 - Medical education
        • 09 - Childhood Cancers
        • 10 - Rare Cancer Policy
  • Objectives
  • Comments
      • FAQs
      • Testimonials
  • Gallery
  • News & Events
      • News
      • Calendar
      • Newsletters
      • Get Involved WGRC news
      • Talked about it
      • Presentations of 1st General Assebly Milan 2017
      • Presentations of 2st General Assebly Milan 2018
  • Dissemination tools
  • JARC Deliverables
  • Contacts
  • Search
 
 

Welcome to JARC

EU Joint Action on Rare Cancers (JARC)

The Joint Action on Rare Cancers (JARC) is aimed to integrate and maximize efforts of the European Union (EU) Commission, EU Member States and all stakeholders to advance quality of care and research on rare cancers.

 

The public health challenge posed by rare cancers combines both the typical problems of rare diseases (such as the limited professional expertise available in the community, or the difficulties in clinical research) and those of cancer, with the need of a timely and appropriate diagnosis and optimal treatment from the very beginning of the patient’s journey. An accurate clinical, pathologic and biological assessment of the disease of the individual patient is key to survival and cure, as well as an expert clinical decision provided by a multidisciplinary team. To this end, proper referral of patients and effective clinical networking are crucial in rare cancers. This is the main reason why JARC decided to shape its efforts, in essence, around the new European Reference Networks (ERNs). European Reference Networks, three of which are specifically devoted to rare cancers, have been conceived by the EU Commission as a means to provide “highly specialised healthcare for rare or low-prevalence complex diseases”. The formal activation of ERNs is a cornerstone in the EU cooperation on rare cancers, and this Joint Action should be instrumental to make them grow up the best way possible. In fact, JARC aims at optimizing the process of creation of the ERNs, by providing them with operational solutions and professional guidance in the areas of quality of care, epidemiology, research and innovation, education and state of the art definition on prevention, diagnosis and treatment of rare cancers.

 Our institution in Milan, Istituto Nazionale Tumori, with a long tradition on several rare cancers, has the privilege to serve as the coordinator of this EU Joint Action. We will try to meet the expectations as much as we can, counting on the exceptional professional skills, the engagement and the passion we have been able to find in all the partners of JARC. Most important, patients will be with us, across all work packages, driving our efforts along the needs of the only end users of all what we can do, in care and research as well.

Looking forward to working together, that is to say, to networking!

Paolo G. Casali

(paolo.casali@istitutotumori.mi.it)

Calendar

«
<
February 2021
>
»
M T W T F S S
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28

NewsLetters

JARC recommendations layman version-1

JARC recommendations layman version 1

EURACAN (Domain 8) – Educational: Rare Thoracic Malignancies

EURACAN Domain 8

OECI Oncology Days - Poznan 2018

OECI Oncology Days 2018

Recent news

Sarcoma as a model to improve diagnosis and clinical care of rare tumors through a European and Latin American multidisciplinary network (SELNET)

by Super User
April 09, 2020
News
Attachments:
Download this file (SELNET_Presentation.pdf)SELNET_Presentation.pdf[ ]406 kB

Rationale of the rare cancer list: a consensus paper from the Joint Action on Rare Cancers (JARC) of the European Union (EU)

by Super User
March 29, 2020
News

Rare Cancer Agenda 2030

by Super User
February 26, 2020
News
Attachments:
Download this file (Rare_Cancer_Agenda_2030.pdf)Rare_Cancer_Agenda_2030.pdf[ ]2316 kB
See all news

About us

EU Joint Action on Rare Cancers (JARC)

The framework for EU stakeholders and policy makers to work together, set the agenda at national level and help provide diagnostics, healthcare and support to all our citizens who suffer from rare cancer.

Work Packages

  • General Info
  • 01 - Coordination
  • 02 - Dissemination
  • 03 - Evaluation
  • 04 - Epidemiology
  • 05 - Assuring Quality of Care
  • 06 - Clinical practice guidelines
  • 07 - Innovation and access to innovation
  • 08 - Medical education
  • 09 - Childhood Cancers
  • 10 - Rare Cancer Policy

News & Events

News
Calendar
Newsletters

Contact info

  • -
  • info@jointactinrarecancers.eu
  • -
footer
JointActionRareCancers © 2021
Web Design by IdealWeb